142 related articles for article (PubMed ID: 2693916)
21. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
22. The effect of ovarian sex steroids on bone mineral status in the oöphorectomized rat and in the human.
Lindsay R; Aitken JM; Hart DM; Purdie D
Postgrad Med J; 1978; 54 Suppl 2():50-8. PubMed ID: 740581
[TBL] [Abstract][Full Text] [Related]
23. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
Trémollieres FA; Pouilles JM; Ribot C
Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
[TBL] [Abstract][Full Text] [Related]
24. Bone loss in oophorectomized Thai women.
Taechakraichana N; Limpaphayom K; Jaisamrarn U; Poshyachinda M
J Med Assoc Thai; 1997 Jun; 80(6):384-90. PubMed ID: 9240013
[TBL] [Abstract][Full Text] [Related]
25. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
Schlemmer A; Hassager C; Delmas PD; Christiansen C
Clin Endocrinol (Oxf); 1994 Jun; 40(6):777-82. PubMed ID: 8033369
[TBL] [Abstract][Full Text] [Related]
26. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density and biochemical markers of bone turnover in peri- and postmenopausal women.
De Leo V; Ditto A; la Marca A; Lanzetta D; Massafra C; Morgante G
Calcif Tissue Int; 2000 Apr; 66(4):263-7. PubMed ID: 10742442
[TBL] [Abstract][Full Text] [Related]
28. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
Wimalawansa SJ
Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
[TBL] [Abstract][Full Text] [Related]
29. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women.
Fioretti P; Gambacciani M; Taponeco F; Melis GB; Capelli N; Spinetti A
Maturitas; 1992 Dec; 15(3):225-32. PubMed ID: 1465036
[TBL] [Abstract][Full Text] [Related]
30. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.
Sacco SM; Jiang JM; Reza-López S; Ma DW; Thompson LU; Ward WE
Menopause; 2009; 16(3):545-54. PubMed ID: 19182694
[TBL] [Abstract][Full Text] [Related]
31. Differential time-related effects of conjugated equine estrogen on bone metabolism in oophorectomized women.
Nozaki M; Inoue Y; Hashimoto K; Ogata R; Nakano H
Int J Gynaecol Obstet; 1998 Jan; 60(1):41-6. PubMed ID: 9506413
[TBL] [Abstract][Full Text] [Related]
32. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women.
Eiken P; Kolthoff N; Nielsen SP
Bone; 1996 Nov; 19(5 Suppl):191S-193S. PubMed ID: 8922661
[TBL] [Abstract][Full Text] [Related]
33. [Observations on bone mineral metabolism in natural and surgical menopause. Role of synthetic salmon calcitonin and calcium on bone turnover].
Ferrante B; Isa L; Uderzo A
Minerva Ginecol; 1993 Mar; 45(3):87-93. PubMed ID: 8332282
[TBL] [Abstract][Full Text] [Related]
34. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
[TBL] [Abstract][Full Text] [Related]
35. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.
Cundy T; Cornish J; Roberts H; Reid IR
Am J Obstet Gynecol; 2002 May; 186(5):978-83. PubMed ID: 12015524
[TBL] [Abstract][Full Text] [Related]
36. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
[TBL] [Abstract][Full Text] [Related]
37. Effects of salmon calcitonin suppositories in the prevention of bone loss in oophorectomized women.
Polatti F; Perotti F; Angelini GP; Vassellatti D; Rapisardi I
Maturitas; 1993 Dec; 18(1):73-6. PubMed ID: 8107619
[TBL] [Abstract][Full Text] [Related]
38. Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis.
Dören M; Nilsson JA; Johnell O
Hum Reprod; 2003 Aug; 18(8):1737-46. PubMed ID: 12871893
[TBL] [Abstract][Full Text] [Related]
39. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.
Watts NB; Notelovitz M; Timmons MC; Addison WA; Wiita B; Downey LJ
Obstet Gynecol; 1995 Apr; 85(4):529-37. PubMed ID: 7898828
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing.
Gnudi S; Mongiorgi R; Figus E; Bertocchi G
Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1153-9. PubMed ID: 2100526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
